MedCity News - Healthcare technology news, life science current …
Get Ready for HLTH 2024: A Preview Guide. HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI ...
MedCity Knowledge Hub
2024年10月21日 · Welcome to the MedCity News Knowledge Hub. Our library of free downloadable content includes white papers, webinars, product guides, case studies, industry analysis and much more, provided by experts and vendors within the healthcare industry. By downloading the content, you may be contacted by the provider.
New CMS rules put the focus on informed patient choice
2019年12月9日 · With the final rule, CMS has signaled to hospitals that they must provide patients with informed choice – not just any choice – of post-acute providers. By Carey Deitz on December 09, 2019 ...
Startups Coverage - MedCity News
Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs. Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug ...
Health Tech Coverage - MedCity News
This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities ...
FDA Approves Iovance Cancer Treatment, the First Cell Therapy for …
2024年2月19日 · The FDA based its approval on the results of an open-label, single-arm Phase 2 clinical trial. Participants had advanced melanoma that was previously treated with at least one systemic therapy ...
BioPharma Coverage - MedCity News
Crescent Biopharma is going public via a reverse merger with GlycoMimetics that will capitalize the combined company with $200 million. Crescent's lead program is a bispecific antibody for cancer ...
5 challenges healthcare faces in 2022 and beyond - MedCity News
2022年1月12日 · 5 challenges healthcare faces in 2022 and beyond. Boston Consulting Group published a new report that identifies five challenges facing healthcare in the upcoming 3 to 5 years as a result of the ...
Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease …
2024年5月28日 · Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction.
5 big healthcare lawsuits of 2020 - MedCity News
2020年12月14日 · Teladoc versus AmWell. Teladoc Health Inc., filed a lawsuit against American Well Corp., alleging its rival is infringing on its patents for several types of technology. The disputed patents cover ...